Perspective Therapeutics Inc. (CATX) stock news · $280.6M cap
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
This CATX news page leads with what Perspective Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for CATX yet. We will not pad this page with generic market recap.
Latest reported CATX revenue for 2022-12-31 was $0. Net income was -$10.8M. CATX currently screens at market cap $280.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CATX stock page; for the tape open the quote page.
CATX stock news FAQ
What is CATX's latest net income?
Latest cached Perspective Therapeutics Inc. (CATX) net income was -$10.8M. Statements: https://lician.com/financials/catx
What is CATX's market cap?
Perspective Therapeutics Inc. (CATX) market cap is $280.6M on the latest cached fundamentals snapshot.
What kind of company is CATX?
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
Where is CATX stock news listed?
Cached stock news for Perspective Therapeutics Inc. (CATX) is listed at https://lician.com/news/catx. Filings: https://lician.com/sec/catx
Not investment advice.